Free Trial
OTCMKTS:KAYS

Kaya (KAYS) Stock Price, News & Analysis

Kaya logo
$0.03 -0.01 (-13.70%)
As of 03:29 PM Eastern

About Kaya Stock (OTCMKTS:KAYS)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.04
52-Week Range
$0.02
$0.05
Volume
4,000 shs
Average Volume
10,351 shs
Market Capitalization
$698.36 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KAYS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kaya and its competitors with MarketBeat's FREE daily newsletter.

KAYS Stock News Headlines

Kaya Holdings, Inc. (KAYS) - Yahoo Finance
Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
Kaya Holdings Delays 10-Q Filing
See More Headlines

KAYS Stock Analysis - Frequently Asked Questions

Kaya's stock was trading at $0.0280 at the beginning of 2025. Since then, KAYS shares have increased by 12.5% and is now trading at $0.0315.

Kaya Holdings, Inc. (OTCMKTS:KAYS) issued its quarterly earnings data on Wednesday, May, 21st. The company reported ($0.04) earnings per share (EPS) for the quarter. The business earned $0.01 million during the quarter.

Shares of KAYS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kaya investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Canopy Growth (CGC), iAnthus Capital (ITHUF), Zynerba Pharmaceuticals (ZYNE), Aurora Cannabis (ACB) and Cara Therapeutics (CARA).

Company Calendar

Last Earnings
5/21/2025
Today
7/11/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
CONSM PD - MISC DIS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:KAYS
CIK
1530746
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.08 million
Net Margins
N/A
Pretax Margin
-19,053.35%
Return on Equity
N/A
Return on Assets
-1,044.25%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
$10 thousand
Price / Sales
69.84
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.77) per share
Price / Book
-0.04

Miscellaneous

Outstanding Shares
22,170,000
Free Float
16,958,000
Market Cap
$698.36 thousand
Optionable
Not Optionable
Beta
0.27
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:KAYS) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners